Novacyt Share News (NCYT)
NCYT Share
NCYT Share
NCYT Share
NCYT Share
NCYT
NCYT Share
NCYT Level 2
NCYT Live
NCYT Broker
NCYT Directors
NCYT Financial
NCYT
NCYT Short
NCYT
Last checked at -
(Sharecast News) - Clinical diagnostics group Novacyt said first-half revenues surged as demand for its Covid-19 testing kit was expected to continue into 2021.
Read more(Sharecast News) - Clinical diagnostics firm Novacyt launched three new products aimed at supporting laboratories testing for Covid-19 on Thursday.
Read more(Sharecast News) - Clinical diagnostics company Novacyt will settle all outstanding debt obligations with Harbert European Growth Capital (HEGC) and Vatel Capital, it announced on Wednesday.
Read more(Sharecast News) - Clinical diagnostics firm Novacyt secured more contract wins for its Primerdesign Covid-19 detection test, but also cautioned that it had suffered a slight setback in France.
Read more(Sharecast News) - Novacyt said on Wednesday that its subsidiary Primerdesign has sold, received orders for or has been contracted to deliver more than ?90m of its Covid-19 test.
Read more(Sharecast News) - Healthcare company Novacyt said it had signed a contract with the UK Department of Health to supply its Covid-19 polymerase chain reaction test.
Read more(Sharecast News) - Biotech group Novacyt said its Covid-19 diagnostic test had been deemed eligible for procurement under the World Health Organisation's Emergency Use Listing process.
Read more(Sharecast News) - Clinical diagnostics company Novacyt announced on Wednesday that it has signed an agreement for certain contract manufacturing services with molecular diagnostics firm Yourgene Health.
Read more(Sharecast News) - Novacyt said on Monday that the US Food and Drug Administration has issued an emergency use authorisation for its Covid-19 test.
Read more(Sharecast News) - Novacyt said on Monday that Public Health England has decided to use a Covid-19 test developed by its molecular diagnostics division, Primerdesign.
Read more(Sharecast News) - Clinical diagnostics company Novacyt updated the market on its Covid-19 coronavirus test, developed by its molecular diagnostics division Primerdesign, on Thursday.
Read more(Sharecast News) - Clinical diagnostics company Novacyt updated the market on its novel Covid-19 coronavirus test developed by its molecular diagnostics division Primerdesign on Friday.
Read more(Sharecast News) - Clinical diagnostics company Novacyt updated the market on the launch of its research-use only test for the Wuhan novel coronavirus strain, or 2019-nCoV, which was developed by its subsidiary Primerdesign as a direct response to the recent outbreak of the respiratory virus in China.
Read more(Sharecast News) - Clinical diagnostics company Novacyt announced on Friday that its molecular diagnostics division Primerdesign has launched a new molecular test for novel coronavirus, or '2019-nCoV'.
Read more(Sharecast News) - Clinical diagnostics specialist Novacyt announced on Friday that its molecular testing division, Primerdesign, has signed an exclusive commercial agreement with Atothis - part of VGS Group - for the distribution of certain molecular diagnostic products in France, for the aquaculture and aquamarine markets.
Read more
Last checked at